Consultation outcome

Consultation on charges for controlled drug licences and precursor chemical licences, registrations, and authorisations

• From: Home Office
• Published: 29 March 2010

This was published under the 2005 to 2010 Labour government

This consultation has concluded

Download the full outcome

Summary Of Responses: Home Office Consultation On The Introduction Of Charges For Controlled Drug And Precursor Chemical Licences

PDF, 77.6 KB, 17 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail of outcome

---

Original consultation

Summary

This consultation considered charging options for controlled drug licences, precursor chemical licences, registrations, and authorisations.

This consultation ran from
29 March 2010 to 11:45pm on 18 June 2010

Consultation description

On 29 March the Home Office launched a consultation on the proposal to introduce charges for controlled drug licences, and precursor chemical licences, registrations, and authorisations.

This consultation paper considered different options for charging. It is accompanied by a consultation stage impact assessment that outlines the costs and benefits of the different options.

Documents

Summary of consultation responses - charges for controlled drug licences

PDF, 77.6 KB, 17 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Summary of responses for the consultation on charges for controlled drug licences and precursor chemical licences, registrations, and authorisations.

PDF, 77.6 KB, 17 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

This is an updated impact assessment for the introduction of charges for controlled drug and precursor chemical licences.

PDF, 164 KB, 32 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Updated impact assessment - charges for controlled drug licences

PDF, 164 KB, 32 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Consultation on charges for controlled drug licences and precursor chemical licences, registrations, and authorisations

PDF, 160 KB, 17 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

This consultation is considering different options for charging for controlled drug licences, and precursor chemical licences, registrations, and authorisations.

PDF, 160 KB, 17 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Impact assessment re-introduction of charges for drugs licences

PDF, 166 KB, 19 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

This impact assessment outlines the cost and benefits of the different options.

PDF, 166 KB, 19 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Published 29 March 2010